Article
Initial evaluation of a new cervical screening strategy combining human papillomavirus genotyping and automated visual evaluation: the Human Papillomavirus-Automated Visual Evaluation Consortium.
Journal of the National Cancer Institute - 1 Oct 2025
Befano Brian, Kalpathy-Cramer Jayashree, Egemen Didem, Inturrisi Federica, Jeronimo José, Rodríguez Ana Cecilia, Campos Nicole, Cremer Miriam, Ribeiro Ana, Ajenifuja Kayode Olusegun, Goldstein Andrew, Haider Amna, Yeates Karen, Madeleine Margaret, Norris Teresa, Figueroa Jacqueline, Alfaro Karla, Raiol Tainá, Adepiti Clement, Norman Judith, Chilinda George Kassim, Mchome Bariki, Donastorg Yeycy, Dlamini Xolisile, Conzuelo Gabriel, Banjo Adekunbiola A, Chone Pauline, Mremi Alex, Benitez Arismendy, Rosberger Zeev, Vantha Te, Prieto-Egido Ignacio, Boyd-Morin Jen, Clark Christopher, Kinder Scott, Wentzensen Nicolas, Desai Kanan, Perkins Rebecca, de Sanjosé Silvia, Schiffman Mark
Abstract excerpt
The HPV-Automated Visual Evaluation Consortium is validating a cervical screening strategy enabling accurate cervical screening in resource-limited settings. A rapid, low-cost human papillomavirus (HPV) assay permits sensitive HPV testing of self-collected vaginal specimens; HPV-negative women are reassured. Triage of positive participants combines HPV genotyping (4 groups in order of cancer risk) and visual...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.